BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2980303)

  • 1. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
    Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
    Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of iopentol in healthy volunteers.
    Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
    Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
    Jakobsen JA; Berg KJ; Waaler A; Andrew E
    Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
    Rathsmann P; Jacobs GF; Müller RD
    Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic, pulmonary and renal haemodynamic effects of intravenously infused iopentol. A comparison in the pig of a new low osmolar non-ionic medium with saline and iohexol.
    Sunnegårdh O; Hietala SO; Wirell S; Ekelund L
    Acta Radiol; 1990 Jul; 31(4):395-9. PubMed ID: 2206697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of iohexol after injection into healthy volunteers.
    Levorstad K; Kolbenstvedt A; Kolmannskog F; Sommerfelt SC; Stormorken H; Andrew E; Sveen K
    Acta Radiol Diagn (Stockh); 1983; 24(3):241-51. PubMed ID: 6624528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of iopentol and iohexol after intravenous injection.
    Jakobsen JA; Kolbenstvedt AN; Berg KJ
    Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iopentol on coagulation and platelet function in vitro and in vivo.
    Stormorken H; Testart MC; Braekke G; Sveen K; Jakobsen JA; Grande T; Andrew E
    Acta Radiol Suppl; 1987; 370():93-6. PubMed ID: 2980322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of iopentol on acetylcholinesterase activity and thrombin time. Comparative studies.
    Dawson P
    Acta Radiol Suppl; 1987; 370():97-9. PubMed ID: 2980323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure.
    Almén T; Bååth L
    Acta Radiol Suppl; 1987; 370():65-8. PubMed ID: 2980315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iopentol on renal function and its use for calculation of glomerular filtration rate in children.
    Stake G; Monclair T; Berg KJ; Rootwelt K; Brekke O
    Acta Radiol; 1995 Jan; 36(1):64-8. PubMed ID: 7833171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a radiographic contrast media (Iopentol) with different viscosities on capillary perfusion in patients with coronary artery disease.
    Jung F; Mrowietz C; Gerk U; Franke RP
    Clin Hemorheol Microcirc; 2013; 53(1-2):201-8. PubMed ID: 22596231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profiles after nonionic dimeric contrast medium injection.
    Böhm I; Speck U; Schild H
    Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.
    Sayegh N; Porée C; Baraton J; Skinningsrud K; Nantois C; Lallemand D
    Eur Radiol; 1996; 6(4):574-7. PubMed ID: 8798046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the risk of ventricular fibrillation by adding sodium to ionic and non-ionic contrast media with low iodine concentration. Coronary perfusion of the isolated rabbit heart with meglumine diatrizoate or iopentol at 140 mg I/ml and 0-154 mmol Na+/l.
    Bååth L; Almén T
    Acta Radiol; 1989; 30(2):207-12. PubMed ID: 2647114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacologic trials with iohexol.
    Aakhus T; Dahlström K; Shaw DD; Leese PT; March L
    Acta Radiol Suppl; 1983; 366():20-2. PubMed ID: 6433655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.